CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Cardiac Arrhythmia Monitoring Devices Market, By Product Type (Resting ECG Devices, ECG Stress Test Devices, Mobile Cardiac Telemetry Monitors, Implantable Cardiac Monitors, Holter Monitors, Event Monitors, Others (Wearable ECG Monitors, Smart ECG Monitors)), By Application (Bradycardia, Tachycardia, Atrial Fibrillation, Premature Contraction, Conduction Disorders, Others (Ventricular Fibrillation, Pacing Monitoring)), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Others (Research Institutes, Specialty Clinics)), , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments:

New product launches:

In March 2020, BioTelemetry, a company that provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services, launched its new Mobile Cardiac Outpatient Telemetry (MCOT) monitor under the Philips brand, targeted at increasing diagnosis efficiency in detecting cardiac arrhythmias. This launch strengthened the company’s cardiac monitoring portfolio.
On September 2022, Medtronic, a global company in healthcare technology, announced that its product, the LINQ II Insertable Cardiac Monitor (ICM) system, is the first-and-only ICM to receive 510(k) clearance by the U.S. Food and Drug Administration (FDA) for use in pediatric patients over the age of 2 who have heart rhythm abnormalities and require long-term, continuous monitoring.
In May 2020, iRhythm, a digital health care company, announced the launch of its new Zio XT Wireless Patch, designed to improve diagnosis of cardiac arrhythmia. The device can continuously monitor heart activity for 14 days.

Acquisition and partnerships:

In July 2020, Philips, a Dutch multinational conglomerate corporation, partnered with BioIntelliSense to integrate medical-grade wearable sensors into Philips’ cardiac diagnostics and monitoring solutions, enhancing its product portfolio.
In September 2019, iRhythm acquired Verily health solutions, an Alphabet company, focused on the development of digital care delivery tools. This allowed iRhythm to enhance its AI, analytics and digital health capabilities.
In June 2021, Boston Scientific, a provider of innovative medical device solutions, completed the acquisition of Farapulse, a producer of pulsed field ablation medical devices for the treatment of atrial fibrillation. This expanded Boston Scientific’s suite of electrophysiology products.